Radiopharm Theranostics Ltd – Filings and Transcripts

NASDAQ: RADX
Share price (8/7/26): $2.80
Market cap (8/7/26): $40.3 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 06/30/25 FY 2025 – amended

ended 06/30/25 FY 2025

Prospectuses and Registrations Filter

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Prospectus supplement

Prospectus supplement for primary offering

Shelf registration

Ownership Filter

Voliotis Dimitris

Laurita Aaron James

Turner Ian Lawrence

News Filter

Announcement Type

Reports Business Update

Announces Closing of US$4.1 Million Registered Direct Offering

Announcement Type

Announces Concurrent US$4.1 Million Registered Direct Offering and Up to Additional A$12.7 (US$8.9) Million Australian Placement and Share Purchase Plan

Proxies

No filings in this category.

Other Filter

Notice of effectiveness

Notice of effectiveness

Correspondence with the SEC

Correspondence with the SEC

Notice of effectiveness